The molecular diagnosis of Gaucher disease has been difficult
Introduction
Gaucher disease is probably the most common glycolipid storage disease. It is caused by an inherited deficiency of the lysosomal enzyme glucocerebrosidase (1) . In addition to the functional gene, a glucocerebrosidase pseudogene has been identified; both the functional gene and the pseudogene appear to be on chromosome 1 (2, 3) and both have been sequenced in their entirety (4) .
Four different single-base substitutions have been reported to cause this disease (Table I) (5) (6) (7) (8) . In some patients diseaseproducing alleles remain unidentified, however. We therefore cloned and sequenced cDNA from cultured skin fibroblasts or lymphoblasts from such individuals. In the course of these studies, we have sequenced a cDNA representing transcript from a fusion gene in which the 5' end is the functional glucocerebrosidase gene and the 3' end is the pseudogene.
In this study we characterize this fusion gene and discuss its importance for understanding the molecular anatomy of the glucocerebrosidase gene complex and its implications for the molecular pathogenesis and diagnosis of Gaucher disease.
Methods
Patient studied. The patient (D.W.) is a 2 1-yr-old female with type 1 (adult type) Gaucher disease. The diagnosis was made at age 3 yr, based on the clinical findings ofhepatosplenomegaly, on the identification of Gaucher cells in bone marrow aspiration, and on the demonstration of a low activity of the acid ,-glucosidase in her white blood cells.
Splenectomy was performed at age 9 yr, after deterioration of her blood counts with frequent bleeding manifestations. Episodic bone pains have occurred since age 10, however, she has not'suffered fractures. At present the most prominent manifestation of her Gaucher disease is massive hepatomegaly with mild abnormalities of her liver function tests.
Cells and RNA. Skin fibroblasts were obtained from a skin biopsy and grown in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum. Cellular RNA was prepared using the guanidium thiocyanate/cesium chloride method (9) ; and the poly(A) rich fraction of RNA was prepared by two purifications with oligo (dT) Sepharose (10) .
Preparation and screening of cDNA library. A cDNA library was prepared and screened as previously described ( 11) with the following modifications. We ligated the cDNA to AZAP (12) and screened our library with two 20-mer oligonucleotide probes (one made to the 5' end of the cDNA and the other to the 3' end so that we could select full-length clones).
The full length clones were sequenced on both strands using modifications of the chain termination dideoxy sequencing technique (13) with a sequenase kit (International Biotechnology, Inc., New Haven, CT) or an AMV reverse transcriptase sequencing kit (Stratagene, La Jolla, CA) according to the recommendations of the suppliers. A set of 1 7-20-mer oligonucleotides were used as primers.
Analysis ofgenomic DNA. High molecular weight genomic DNA was prepared from white blood cells according to established methods (14) .
The polymerase chain reactions were performed as described (15) for identification of the crossover site of the fusion gene.
Ssp I digests were made by incubating 10 Mg of DNA in 400 Ml of a buffer (10 mM Tris-Ci pH 7.5, 105 mM NaCI 10 mM Mg Cl2, I mM DTT, 0.02% gelatin). Another 120 U of Ssp I was then added and incubation was continued for an additional 2 h. Electrophoresis was performed in 0.36% ultrapure agarose (Bethesda Research Laboratories, Gaithersburg, MD) poured on a 3-mm 1% base in 40 mM Tris-Cl, 20 mM Na acetate, 18 mM NaCI, 2 mM EDTA, pH 8.05 buffer. Electrophoresis was carried out for 18 h at 2 V/cm. The gel was then treated with 0.25 M HC1 for 15 min alkalinized with 0.5 M NaOH in 1.5 M NaCl for I h and finally treated with 0.5 M Tris pH 7.5 in 3 M NaCl for 2 h. The DNA was transferred from the gel to nitrocellulose for 3 d in lOX SSC (14) . The gels were developed with the cDNA probe described previously (16) , applying 35,000 cpm/mm2 of nitrocellulose in 12 ml of annealing mix (50% formamide, I X Denhardt's solution, 10 mM Hepes, pH 7.4, 3X SSC, 0.1 mg/ml salmon sperm DNA [denatured]) at 420C. The filter was washed at 50-550C in 350 ml of 0.1 X SSC, 0.1% SDS three times for 1 h each.
Sac II digests were performed by adding 200 U ofSac II to 500 Ml of buffer (6 mM Tris-CI pH 7.5, 6 mM MgCl2, 6 mM NaCI, I mM DTT, 0.02% gelatin) containing 10 Ag of DNA, incubating for 4 h at 37?C.
The gel was treated with acid, neutralized, and transferred to nitrocellulose in a manner identical to that used for the Ssp I digest. The filter was developed using the same probe at 55,000 cpm/mm2. All of these four point mutations match exactly the sequence found normally in the glucocerebrosidase pseudogene downstream from nucleotide 1300 on the cDNA sequence (4, 1 1). To study the molecular mechanism of the apparent recombination of active gene and pseudogene we performed Southern blot analysis of genomic DNA, digested with the restriction endonucleases Sac II and Ssp I separately (Fig. 1 ). An attempt to improve the resolution of the pattern on the gel by using rotating agarose gel electrophoresis (17) These studies provide evidence for rearrangement of DNA in the glucocerebrosidase gene complex. Unequal crossover apparently has occurred between the functional glucocerebrosidase gene and the pseudogene as the molecular event responsible for the creation of the fusion gene. The loss of DNA between the gene and pseudogene accounts for the shorter than normal fragments found on restriction analyses.
Results
In determining the crossover region, we analyzed genomic DNA by the polymerase chain reaction technique, using our previously described methods for the detection of mutations 1226 and 1448 (15) . This analysis indicates that the transition from the functional gene to the pseudogene occurred between nucleotides 5933 and 6272 of the glucocerebrosidase gene. Since the sequences of the gene and pseudogene are identical between these two nucleotides, the exact point of crossover could not be determined. 
Discussion
We report the occurrence in a patient with adult-type Gaucher disease of a cDNA representing transcription from a fusion gene, in which the 5' end is the functional glucocerebrosidase gene and the 3' end is the pseudogene. A map of the glucocerebrosidase gene/pseudogene complex reveals that the restriction endonuclease Sac II cuts outside the complex, yielding a single fragment -49 kb in length (Fig. 2) . If the fusion gene had arisen through the process of gene conversion (18) , the length of this fragment should remain unaltered in the affected individuals. Similarly, if a long transcript encompassing both the gene and the pseudogene had been processed in such a way as to create the mRNA that was detected, the restriction pattern would have been unaltered. The appearance of an altered, shorter fragment in the Sac II digest of our patient proves that the fusion gene was created through an unequal crossover event.
This conclusion is further confirmed by the results of the Ssp I analysis. Normally (in healthy individuals and in Gaucher patients), Ssp I cuts outside the glucocerebrosidase gene complex and inside the intergenic region, producing two major bands when hybridizing to the glucocerebrosidase cDNA. Since the intergenic sequence is missing in the fusion gene described herein, there should be a loss of the Ssp I intergenic site(s) of A fusion gene containing the 5' portion of the 6-globin gene and the 3' part of the fl-globin gene produces a form of thalassemia in which the abnormal hemoglobin is designated hemoglobin Lepore. The fusion gene we describe here is the only other inherited disease of man of which we are aware in which a fusion gene producing an abnormal protein has been identified as the result of crossing over between two different genes.
Similar events, presumably representing crossing over within a gene that generates a duplication, have been described in the case of Duchenne muscular dystrophy (19) and in the LDL receptor gene (20) . Color blindness is apparently frequently due to crossing over between genes for green and red pigment (21, 22) . Crossovers between virtually identical genes, the a-globin genes, accounts for the deletions seen in a-thalassemia-2 (23) but here the fusion protein is normal and the disease state results from the loss of a copy rather than the formation of an abnormal one.
The existence of this "Lepore"-like glucocerebrosidase gene is an experiment of nature that provides data regarding the molecular anatomy of the glucocerebrosidase genes on chromosome 1 and also has significant implications in respect to the molecular diagnosis and pathogenesis of Gaucher disease. The fact that the 5' end of the fusion gene was derived from the functional gene indicates that the functional gene is 5' to the pseudogene; the complex that would be formed if the Fig. 2 ).
The fusion gene that we have detected would drastically impair the production or the stability of glucocerebrosidase. It contains a base change occurring normally in the pseudogene that causes severe Gaucher disease when present as a point mutation in the functional gene (5) . In addition another downstream base pair substitution produces another alapro substitution at nucleotide 1483.
The analysis of mutations in Gaucher disease patients has been difficult due to the existence of several different abnormal alleles and because of the need to separate the glucocerebrosidase gene from its 95% homologous pseudogene. The occurrence of fusion genes makes such analysis even more complicated, but fortunately crossovers of the type we have described here are uncommon. In any case, this experiment does yield interesting information regarding the structure of this important gene complex.
